One hundred and forty patients were treated with weekly EndoTAG-@ ( @ mg/m ( @ ) ) plus paclitaxel ( @ mg/m ( @ ) ) , twice weekly EndoTAG-@ ( @ @ mg/m ( @ ) ) , or weekly paclitaxel ( @ mg/m ( @ ) ) for greater than or equal to four cycles ( @-week treatment + @-week rest ) or until progression/toxicity .